Cargando…
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
Sarcomas are a heterogeneous group of solid tumors arising from either soft tissues or bone, accounting for approximately 1% of all cancers in adults. Management of these diseases has changed little over the past 10 years, with the exception of treatment of gastrointestinal stromal tumors. Reasons f...
Autores principales: | Somaiah, Neeta, von Mehren, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514064/ https://www.ncbi.nlm.nih.gov/pubmed/23226072 http://dx.doi.org/10.2147/CMAR.S23257 |
Ejemplares similares
-
Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012) -
Targeted Treatment of Soft-Tissue Sarcoma
por: Riskjell, Anne Iren, et al.
Publicado: (2023) -
Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023) -
Role of trabectedin in the treatment of soft tissue sarcoma
por: Christinat, Alexandre, et al.
Publicado: (2009) -
Treatment of Adult Soft Tissue Sarcomas: An Overview
por: Arifi, Samia, et al.
Publicado: (2015)